SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-009197
Filing Date
2022-04-14
Accepted
2022-04-14 16:03:32
Documents
8
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A esperion-definitive2021pro.htm DEF 14A 1212357
2 blookersigv2a.jpg GRAPHIC 5422
3 espe_rmxrgbxfcxpos002a.jpg GRAPHIC 44145
4 proxycard1backa.jpg GRAPHIC 131464
5 proxycard1fronta.jpg GRAPHIC 89094
6 proxycard2backa.jpg GRAPHIC 86718
7 proxycard2fronta.jpg GRAPHIC 102522
8 sheldonsignaturea.jpg GRAPHIC 20271
  Complete submission text file 0001628280-22-009197.txt   1850963
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35986 | Film No.: 22827225
SIC: 2834 Pharmaceutical Preparations